Work

Carfilzomib and lenalidomide response related to VEGF and VEGFR2 germline polymorphisms

Year: 2017

Type: article

Source: Cancer Chemotherapy and Pharmacology

DOI: 10.1007/s00280-017-3323-8

Authors: Tristan M. Sissung, Cody J. Peer, Neha Korde, Sham Mailankody, Dickran Kazandjian, David J. Venzon, Ola Landgren, William D. Figg

Institutions: National Cancer Institute, Memorial Sloan Kettering Cancer Center, Center for Cancer Research, National Institutes of Health

Language: English

Topic: Multiple Myeloma Research and Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: National Institutes of Health, National Cancer Institute

Awards: Clinical Pharmacogenetics, Genetics and Molecular Mechanisms of Prostate Cancer, Clinical Pharmacogenetics

OpenAlex ID: W2613546676

FWCI: 0.421

Cites: 15

Cited by: 6

Related to: 10